InvestorsHub Logo
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

Re: ariadndndough post# 26236

Friday, 02/08/2013 12:41:31 AM

Friday, February 08, 2013 12:41:31 AM

Post# of 80490
As a point of reference,
Rachel McMinn's September 2012 piece had implied US sales of $68 for Sprycel - $33 for Tasigna and (her average of the two) estimate of $52 for Iclusig.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.